Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
TransMedics Group (TMDX) PT Raised to $142 at Canaccord Genuity
-
Form 8.3 - [MARLOWE PLC - 14 07 2025] - (CGWL)
-
Operational Update
-
Hims & Hers to Announce Second Quarter 2025 Financial Results on August 4, 2025
-
VIZSLA SILVER ANNOUNCES CLOSING OF OVER-ALLOTMENT OPTION IN FULL
-
Evolent To Release Second Quarter 2025 Financial Results on Thursday, August 7, 2025
-
Tylenol maker Kenvue ousts CEO amid board's strategic review
-
Canaccord Genuity Reiterates Buy Rating on Central Garden & Pet Co. (CENT)
-
Vertical Aerospace Ltd. (EVTL) PT Lowered to $11 at Canaccord Genuity
-
Form 8.3 - [ALPHA GROUP INTERNATIONAL PLC - 11 07 2025] - (CGAML)
-
Thor Explorations Announces Q2 2025 Operating Update
-
MP Materials (MP) PT Raised to $55 at Canaccord Genuity
-
Form 8.3 - [ALPHA GROUP INTERNATIONAL PLC - 10 07 2025] - (CGAML)
-
Canaccord Genuity Downgrades North American Construction Group (NOA:CN) (NOA) to Hold
-
Form 8.3 - [MARLOWE PLC - 09 07 2025] - (CGWL)
-
Canaccord Genuity Reiterates Buy Rating on Exact Sciences (EXAS)
-
Canaccord Genuity Reiterates Buy Rating on GH Research PLC (GHRS)
-
Canaccord Genuity Reiterates Buy Rating on Ultragenyx Pharma (RARE)
-
EZCORP (EZPW) PT Raised to $25 at Canaccord Genuity
-
Rhythm Pharmaceuticals prices $175 million stock offering at $85 per share
-
Rhythm Pharmaceuticals, Inc. Announces Pricing of Upsized Public Offering of Common Stock
-
Total Voting Rights
-
Rhythm Pharmaceuticals announces $150 million stock offering
-
Rhythm Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
-
GK Resources and Syntholene Energy Announce Brokered Private Placement of up to C$4.0 Million
-
SGHC Limited (SGHC) PT Raised to $15 at Canaccord Genuity
-
Canaccord Genuity Reiterates Hold Rating on Edwards Lifesciences (EW)
-
Canaccord Genuity Starts Redwire (RDW) at Buy
-
Arrow Announces the Resignation of Director Anthony Zaidi
-
Priyanka Capital Announces Completion of Upsized $63.5 Million Brokered Offering in Pecoy SPV
-
Hemisphere Energy Announces Normal Course Issuer Bid Renewal
-
Solomon Partners Hires Jonathan Hemmert as a Partner to Build a Dedicated Professional Services Group
-
Glass Lewis backs WonderFi-Robinhood deal, recommends FOR vote
-
Leading Independent Proxy Advisory Firm Glass Lewis Recommends WonderFi Shareholders Vote FOR the Proposed Transaction with Robinhood
-
Canaccord Genuity Reiterates Buy Rating on Archer Aviation Inc. (ACHR)
-
Canaccord Genuity Reiterates Buy Rating on Apogee Therapeutics Inc (APGE)
-
Cybin Inc. (CYBN) PT Lowered to $70 at Canaccord Genuity
-
Company name change to Amaroq Ltd.
-
Ensurge Micropower ASA – Business Update and Contemplated Fully Underwritten Private Placement
-
Enovix (ENVX) Declares Shareholder Warrant Dividend
-
Enovix Declares Shareholder Warrant Dividend
-
Form 8.3 - [MARLOWE PLC - 04 07 2025] - (CGWL)
-
Helen of Troy (HELE) PT Lowered to $47 at Canaccord Genuity
-
Canaccord Genuity Starts Boku Inc (BOKU:LN) at Buy
-
Form 8.3 - [MARLOWE PLC - 03 07 2025] - (CGWL)
-
Touchstone Exploration Inc. Announces Employee Share Purchase Plan & PDMR Purchases
-
Minaurum Gold Inc. Announces Closing of Brokered Life Offering for Gross Proceeds of C$9.2M
-
Great Pacific Gold Announces Closing of Upsized $16.9 Million Private Placement Financing Led by Canaccord Genuity Corp
-
Form 8.3 - [MARLOWE PLC - 02 07 2025] - (CGWL)
-
Silver Storm Closes the First Tranche of Its Non-Brokered LIFE Financing for Gross Proceeds of $3.87 Million

